Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

BRSCW Applicant: Morre - NOX Technologies Inc. (2009)

324
Morre, D. JamesNOX Technologies
tNOX, ENOX, ENOX2, NXOB826, NX034
Other
Proteomics
Breast and Gynecologic Cancers Research

Evaluation using NOX Technologies ECTO-NOX blot diagnostic 2-D gel electrophoretic cancer detection system in combination with a sandwich ELISA of our derivation

To obtain preliminary indications of utility for serum detection of breast and ovarian cancer.
sandwich ELISA

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


News

The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 06/26/2014


Please click here to register for the 9th EDRN Scientific Workshop from September 8-10, 2014, in Bethesda, Maryland. The meeting registration page also has agendas and hotel reservation information.
Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html